FemBloc® Permanent Contraception - Early Pivotal Trial

NCT ID: NCT03433911

Last Updated: 2025-01-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

240 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-02-02

Study Completion Date

2025-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prospective, multi-center, international, non-randomized, two-arm study of subjects undergoing either FemBloc or laparoscopic bilateral tubal sterilization (Control). The FemBloc group total study duration will be approximately 65 months. The laparoscopic tubal sterilization (Control) group total study duration will be approximately 62 months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Contraception

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

FemBloc

Investigational device and procedure

Group Type EXPERIMENTAL

FemBloc

Intervention Type DEVICE

Treatment with FemBloc for women who desire permanent birth control (female sterilization)

Control

Laparoscopic bilateral tubal sterilization

Group Type ACTIVE_COMPARATOR

Laparoscopic bilateral tubal sterilization

Intervention Type PROCEDURE

Laparoscopic bilateral tubal sterilization for women who desire permanent birth control (female sterilization)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

FemBloc

Treatment with FemBloc for women who desire permanent birth control (female sterilization)

Intervention Type DEVICE

Laparoscopic bilateral tubal sterilization

Laparoscopic bilateral tubal sterilization for women who desire permanent birth control (female sterilization)

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female, 21 - 45 years of age desiring permanent birth control
* Sexually active with male partner
* For FemBloc Arm:

* Regular menstrual cycle for last 3 months or on hormonal contraceptives
* For Control Arm:

* Undergoing planned laparoscopic bilateral tubal sterilization

Exclusion Criteria

* Uncertainty about the desire to end fertility
* Known or suspected pregnancy
* Prior tubal surgery, including sterilization attempt
* Prior endometrial ablation
* Presence, suspicion, or previous history of gynecologic malignancy
* Abnormal uterine bleeding requiring evaluation or treatment
* Scheduled to undergo concomitant intrauterine procedures at the time of procedure(s)
Minimum Eligible Age

21 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Femasys Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sponsor

Role: STUDY_DIRECTOR

Medical Affairs & Clinical Development

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

New Horizons Clinical Trials

Chandler, Arizona, United States

Site Status

Stanford University

Stanford, California, United States

Site Status

Altus Research Inc.

Lake Worth, Florida, United States

Site Status

Rosemark Womencare Specialists

Idaho Falls, Idaho, United States

Site Status

Women's Health Advantage

Fort Wayne, Indiana, United States

Site Status

Rutgers, The State University of New Jersey

Newark, New Jersey, United States

Site Status

Columbia University Medical Center

New York, New York, United States

Site Status

Wake Research Associates, LLC

Raleigh, North Carolina, United States

Site Status

University Hospitals Cleveland Medical Center

Beachwood, Ohio, United States

Site Status

Amy Brenner MD & Associates

Mason, Ohio, United States

Site Status

Chattanooga Medical Research LLC

Chattanooga, Tennessee, United States

Site Status

University of Utah

Salt Lake City, Utah, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

http://www.fembloc.com/

FemBloc Study Website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CP-100-007

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Robot Based Tympanic Tube Placement
NCT03569943 WITHDRAWN NA